Herbert G. Sayer
Erfurt, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Stability of Thermoablation Antenna Using a Patient-Mounted Navigation System: Initial Clinical Experience.
Journal: Journal of medical imaging and radiation oncology
Published: May 25, 2024
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.
Journal: Bone marrow transplantation
Published: November 12, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Journal: Annals of hematology
Published: October 12, 2022
Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort.
Journal: Oncology research and treatment
Published: May 25, 2022
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Journal: Annals of hematology
Published: September 16, 2021
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy.
Journal: Journal of cancer research and clinical oncology
Published: August 20, 2021
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Journal: European journal of haematology
Published: June 11, 2021
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
Journal: Journal of cancer research and clinical oncology
Published: May 26, 2021
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Journal: Annals of hematology
Published: November 10, 2020
Allogeneic stem cell transplantation for mantle cell lymphoma-update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74).
Journal: Annals of hematology
Published: August 10, 2020
Last Updated: 09/26/2026